Inoveon Overview

  • Founded
  • 1997
  • Status
  • Acquired/​Merged
  • Employees
  • 7
  • Latest Deal Type
  • M&A

Inoveon General Information


Provider of solutions to detect, and stage and monitor diseases affecting the eye intended to preserve eyesight. The company's technology system helps in detection, staging, monitoring, and treatment of diabetic retinopathy and macular edema, enabling physicians to provide quality care to patients with eye-related diseases.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Parent Company
Primary Office
  • 800 Research Parkway
  • Suite 370
  • Oklahoma City, OK 73104
  • United States
+1 (405) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Inoveon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 29-Dec-2020 000.00 Completed Generating Revenue
7. Later Stage VC (Series D) 19-Jun-2007 00.00 000.00 Completed Generating Revenue
6. Convertible Debt 14-Feb-2006 00.000 0000 Completed Generating Revenue
5. Later Stage VC (Series C) 22-Dec-2004 000 000.00 Completed Generating Revenue
4. Early Stage VC (Series B) 24-Oct-2002 000.00 000.00 Completed Generating Revenue
3. Bridge 01-Apr-2002 000 00.00 Completed Generating Revenue/Not Profitable
2. Early Stage VC 27-Mar-2001 $4.4M Completed Product Development
1. Early Stage VC (Series A) 01-Dec-1998 $4.4M $4.4M Completed Product Development
To view Inoveon’s complete valuation and funding history, request access »

Inoveon Executive Team (5)

Name Title Board Seat Contact Info
Carsten Becker Chief Financial Officer
Carl Gibson Chief Operating Officer & Board Member
Stephen Fransen MD Co-Founder
You’re viewing 3 of 5 executive team members. Get the full list »

Inoveon Board Members (2)

Name Representing Role Since
Carl Gibson Inoveon Chief Operating Officer & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Inoveon Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Inoveon Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CenterPoint Ventures Venture Capital Minority 000 0000 000000 0
Chisholm Private Capital Partners Venture Capital Minority 000 0000 000000 0
Chrysalis Ventures Venture Capital Minority 000 0000 000000 0
Council Oak Partners PE/Buyout Minority 000 0000 000000 0
Eli Lilly Corporation Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »